Jiangsu Guoxin Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Jiangsu Guoxin şirketinin toplam hissedar öz sermayesi CN¥44.1B ve toplam borcu CN¥39.2B olup, bu da borç-öz sermaye oranını 88.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥91.0B ve CN¥46.9B dir. Jiangsu Guoxin 'in FAVÖK'ü CN¥3.5B faiz karşılama oranı -2.6 dur. Şirketin CN¥19.3B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

88.9%

Borç/özkaynak oranı

CN¥39.23b

Borç

Faiz karşılama oranı	-2.6x
Nakit	CN¥19.32b
Eşitlik	CN¥44.12b
Toplam yükümlülükler	CN¥46.89b
Toplam varlıklar	CN¥91.02b

Son finansal sağlık güncellemeleri

Is Jiangsu Guoxin (SZSE:002608) A Risky Investment?

Sep 26

Recent updates

Jiangsu Guoxin's (SZSE:002608) Performance Is Even Better Than Its Earnings Suggest

Nov 07

Little Excitement Around Jiangsu Guoxin Corp. Ltd.'s (SZSE:002608) Earnings

Oct 21

Is Jiangsu Guoxin (SZSE:002608) A Risky Investment?

Sep 26

Jiangsu Guoxin (SZSE:002608) Might Be Having Difficulty Using Its Capital Effectively

Aug 07

Jiangsu Guoxin Corp. Ltd. (SZSE:002608) Looks Inexpensive But Perhaps Not Attractive Enough

Jun 16

Solid Earnings Reflect Jiangsu Guoxin's (SZSE:002608) Strength As A Business

May 03

Jiangsu Guoxin Corp. Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Apr 15

Investors Appear Satisfied With Jiangsu Guoxin Corp. Ltd.'s (SZSE:002608) Prospects

Feb 29

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 002608 'nin kısa vadeli varlıkları ( CN¥26.4B ) kısa vadeli yükümlülüklerini ( CN¥19.7B ) aşıyor.

Uzun Vadeli Yükümlülükler: 002608 'un kısa vadeli varlıkları ( CN¥26.4B ) uzun vadeli yükümlülüklerini ( CN¥27.2B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 002608 'nin net borç/öz sermaye oranı ( 45.1% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 002608 şirketinin borç/öz sermaye oranı son 5 yılda 68.2% seviyesinden 88.9% seviyesine yükseldi.

Borç Kapsamı: 002608 'nin borcu işletme nakit akışı ( 13.8% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 002608 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Jiangsu Guoxin Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Jiangsu Guoxin (SZSE:002608) A Risky Investment?

Recent updates

Jiangsu Guoxin's (SZSE:002608) Performance Is Even Better Than Its Earnings Suggest

Third quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.22 in 3Q 2023)

Little Excitement Around Jiangsu Guoxin Corp. Ltd.'s (SZSE:002608) Earnings

Jiangsu Guoxin Corp. Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 19%

Is Jiangsu Guoxin (SZSE:002608) A Risky Investment?

Second quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.23 in 2Q 2023)

Jiangsu Guoxin (SZSE:002608) Might Be Having Difficulty Using Its Capital Effectively

Dividend of CN¥0.10 announced

Jiangsu Guoxin Corp. Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Jiangsu Guoxin Corp. Ltd. (SZSE:002608) Looks Inexpensive But Perhaps Not Attractive Enough

Jiangsu Guoxin Corp. Ltd. Approves Cash Dividend for the Year 2023

Solid Earnings Reflect Jiangsu Guoxin's (SZSE:002608) Strength As A Business

First quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.068 in 1Q 2023)

Consensus EPS estimates fall by 11%, revenue upgraded

Jiangsu Guoxin Corp. Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Jiangsu Guoxin Corp. Ltd., Annual General Meeting, May 08, 2024

Jiangsu Guoxin Corp. Ltd., Annual General Meeting, May 08, 2024

Jiangsu Guoxin Corp. Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investors Appear Satisfied With Jiangsu Guoxin Corp. Ltd.'s (SZSE:002608) Prospects

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.05 loss in 3Q 2022)

Jiangsu Guoxin Corp. Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.12 in 2Q 2022)

Jiangsu Guoxin Corp. Ltd. Announces Final Profit Distribution for the Year 2022, Payable on 13 July 2023

Jiangsu Guoxin Corp. Ltd. Approves Cash Dividend for the Year 2022

Full year 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.09 loss in FY 2021)

Full year 2022 earnings released: CN¥0.019 loss per share (vs CN¥0.09 loss in FY 2021)

Jiangsu Guoxin Corp. Ltd. Announces Board Appointments

High number of new and inexperienced directors

Third quarter 2022 earnings released: CN¥0.05 loss per share (vs CN¥0.053 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 2Q 2021)

Jiangsu Guoxin Corp. Ltd. Announces Board Appointments

First quarter 2022 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

Third quarter 2021 earnings released: CN¥0.053 loss per share (vs CN¥0.16 profit in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.18 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.13 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.60 (vs CN¥0.64 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.59 (vs CN¥0.64 in FY 2019)

New 90-day low: CN¥6.08

Jiangsu Guoxin Corp. Ltd.(XSEC:002608) dropped from S&P Global BMI Index

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥7.85

New 90-day high: CN¥6.83

Third quarter earnings released

New 90-day low: CN¥6.37

New 90-day high - CN¥7.27

First half earnings released

Jiangsu Guoxin Corp. Ltd. to Report First Half, 2020 Results on Aug 28, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin